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Introduction
The B cell response plays a vital role in the defence against a 
variety of pathogens encountered throughout life. B cell responses 
are commonly categorised into two distinct subgroups known 
as “T cell-dependent” and “T cell-independent” responses. In 
T cell-dependent B cell responses, B cells are typically activated 
through recognition of their cognate antigen combined with 
cytokine and CD40 stimulation in the form of “T cell help” in the 
secondary or tertiary lymphoid tissues. Upon activation there are 
a number of differentiation pathways available to these B cells, 
with the three major options being: 1) to become short lived plasma 
cells, capable of secreting antibody in response to initial infection; 
or undergo clonal expansion, somatic hypermutation (SHM) and 
class switch recombination (CSR) in the germinal centre to subse-
quently become either 2) long-lived plasma cells, which home to 
the bone marrow, or 3) long-lived memory B cells1–4.
Human memory B cells were originally isolated based on their 
lack of IgD expression, which had been identified as a naïve 
B cell marker5,6. Subsequent to this, two papers identified CD27 
as a general marker of B cell memory7,8. This newly identified 
memory B cell marker allowed for a more refined study of the 
bulk memory B cell population. However, the CD27+ population is 
heterogeneous and is comprised of roughly 10–20% IgM+ IgD+, 
40–50% IgM+ IgD- and 30–40% IgM- IgD- isotype switched 
cells. The existence of IgM+ CD27+ cells as T cell-dependent 
memory B cells has been hotly debated9. Nonetheless these IgM+ 
memory B cells do show classical memory cell hallmarks, such 
as somatically hypermutated V genes8,10, and a recent in depth 
study of this population has shown that they participate in T cell- 
dependent recall responses and show similar transcriptome patterns 
to the IgM- IgD- CD27+ population11. Therefore, to gain a more 
complete understanding of the memory B cell response, it will be 
important to delineate the functionality of these T cell-dependent 
memory B cell subsets.
Memory B cells are central players of long-term humoral 
immunity, capable of responding rapidly and with high affinity 
to secondary encounter with an antigen. Successful vaccination 
readily induces long-lived B cell memory that is maintained for 
decades12,13. Recent observations have shown that vaccination or 
infection does not, however, produce a homogenous population 
of memory B cells, but a constellation of subsets depending 
on the kinetic time point, location, and type of vaccination 
or infection14,15. The frequency of memory B cell subsets is 
variable, with some subsets such as immunoglobulin (Ig)D+ 
IgM- CD27+ memory B cells forming only 1–3% of peripheral 
blood B cells14, and this number could be even smaller when 
looking at vaccine induced antigen specific responses. Despite 
their rarity, such subsets could play an important role in the 
immune response to infection and/or vaccination. For instance, 
IgM+ memory B cells have recently been shown to play an 
important role in the early response to malaria re-challenge using 
a murine model16, whilst human IgM+ memory B cells have 
been shown to play a role in decreasing Rotavirus viral load17.
A number of different assays have been developed to facilitate 
the investigation of the memory B cell repertoire in response to 
vaccination or infection. The use of fluorophore-tagged antigen to 
identify antigen-specific memory B cells has been attempted with 
some success18–20. However, optimisation of antigen-specific B cell 
staining is a complex process and carries a number of potential 
pitfalls. Three of the major issues with antigen-specific staining 
are the scarcity of the cells, the low levels of surface Ig expres-
sion and the need for a highly purified antigen, which can make 
identification of antigen specific B cells difficult21. In an effort to 
avoid these issues, Epstein-Barr virus immortalisation of memory 
B cells followed by screening of cell culture supernatant for antigen 
reactivity has been performed. This technique, however, has its own 
limitations, such as immortalisation biases and low immortalisa-
tion efficiency22,23. A more recent transformation based approach 
utilises a retroviral transduction system to induce expression of 
the antiapoptotic factors Bcl-6 and Bcl-xL, which, when combined 
with IL-21 and CD154 allows memory B cells to differentiate into 
long lived antibody secreting cells (ASCs) that still retain surface 
BCR expression24,25.
Ex vivo expansion and differentiation of memory B cells into 
ASCs is an alternative technique that has now been widely 
adopted in the field, owing to its simplicity and versatility. This 
technique allows a variety of different functional assays to be 
undertaken allowing for a more complete interrogation of the 
memory B cell repertoire. ELISA and ELISpot assays can quan-
tify antigen-specific Ig and define the Ig isotype secreted by the 
expanded memory B cells, viral neutralisation assays assess 
the functionality of the antibody, and bio-layer interferometry 
permits measurement of the antibody binding kinetics. For 
example, ex vivo memory B cell expansion has been recently 
used to identify an extremely potent HIV-1 broadly neutralis-
ing antibody named N6, which could not be identified through 
flow cytometry based approaches26. Overall these downstream 
assays can be applied to answer a number of important biological 
questions. For example, investigating the magnitude of the 
memory B cell subset response to vaccination or infection, the 
            Amendments from Version 1
The changes made to version two of the manuscript “Optimisation 
of ex vivo memory B cell expansion/differentiation for interrogation 
of rare peripheral memory B cell subset responses” were largely 
made to reflect and answer the comments made by the reviewers. 
We have added an additional table (Table 3) in the Methods 
section to highlight the primer sequences used in the NGS 
experiments.
The biggest change in the manuscript was the addition of somatic 
hypermutation analysis of the whole IgH V region rather than 
solely focusing on CDRH3 length in our “Characterisation of the 
impact of the memory B cell culture conditions on the Ig locus” 
Results section. 
We have also updated our comments on the decrease in Ig levels 
over the 10 day culture period, whilst the Discussion has also 
been shortened and adapted to become more focused.
We have also made alterations to the data presented in Figure 4, 
Figure 5 and Supplementary Figure 6.
See referee reports
REVISED
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reactivity of the recall response between different memory B cell 
subsets and mapping the specificity of the response and how this 
evolves between different memory B cell subsets26.
To date, a plethora of different conditions capable of induc-
ing memory B cell expansion/differentiation have been pub-
lished. Combinations of cytokines, such as IL-2, IL-10, 
IL-2127–33, pattern recognition receptor agonists such as R848, 
CpG ODN200628,30,34 and CD40 stimulation35, form the basis of 
most published conditions. In 2009, Pinna et al.30 published one 
of the most widely utilised methodologies owing to its simplicity 
and robust expansion capability. This methodology consisted of 
the addition of IL-2 and R848 to isolated B cells, with irradiated 
peripheral blood mononuclear cells (PBMCs) acting as the 
CD154 (CD40-ligand) source. However, despite detailed analy-
sis of the origins of memory B cell subsets36 and optimisation of 
ex vivo memory B cell culture conditions for the investigation 
of the IgG+ response37, no conditions to date have been inves-
tigated for their ability to induce maximal and proportional 
memory B cell expansion/differentiation across the CD27+ IgM- 
IgD-, IgM+ IgD+ and IgM+ IgD- subsets. Defining such conditions 
will be important in allowing a comprehensive assessment of how 
the memory B cell response evolves between these subsets across 
time in response to infection and/or vaccination. Identification of 
these conditions will also have implications for the study of rare 
polyreactive memory B cells which are difficult to fully investi-
gate using conventional fluorophore tagged antigen approaches. 
By inducing expansion and differentiation of single memory 
B cells, including the IgM+ subsets, the culture supernatants 
could easily be screened for reactivity to multiple antigens.
In this study, we screened a wide variety of published memory 
B cell expansion stimuli and then utilised a Design of Experi-
ments (DoE) approach to identify the optimal combination across 
different CD27+ memory B cell subsets. The expansion and 
differentiation of memory B cells to ASCs was then tracked 
via flow cytometry and IgH deep sequencing. 
Methods
PBMC and memory B cell isolation
Written informed consent was obtained from all 10 donors. 
All samples were collected under protocols approved by the 
Imperial College NHS Trust Tissue Bank and the National 
Research Ethics Committee in accordance with the Human Tissue 
Act 2004. Approval for this project was granted by the Impe-
rial College Healthcare Tissue Bank, under their HTA research 
licence, and ethics thus conveyed through this process by the 
Multi Research Ethics Committee (MREC), Wales. PBMCs 
were isolated by centrifugation (400 × g, 30 min, no brake) over 
Histopaque-1077 (Sigma Aldrich, Dorset, UK). CD27+ memory 
B cells were then isolated using the Memory B Cell Isolation 
Kit (Miltenyi Biotec, Surrey, UK) following the manufacturer’s 
instructions. Due to the rarity of some subsets the same donors 
could not be used throughout the whole study. Therefore, memory 
B cells were isolated from 10 different donors and replicates 
from 1–3 donors used per individual experiment. This meant that 
inter donor variability was measured throughout each experiment 
but not between different experiments. However, it should be 
noted that all isolated memory B cells and subsets from all donors 
were well within the expected normal range.
Literature review
In order to identify stimuli associated with current 
memory B cell culture protocols, a literature review was carried 
out using the following search terms: memory B cell ELISpot, 
memory B cell culture, memory B cell stimulation, mem-
ory B cell differentiation and memory B cell expansion using 
the NCBI PubMed database (https://www.ncbi.nlm.nih.gov/
pubmed). The results of this literature review can be seen in 
Table 1.
Table 1. Expansion stimuli including the concentrations used in both the original screening 
process and the Design of Experiments (DoE) process. Concentrations were chosen to reflect those 
shown in the literature. APRIL concentrations were chosen to mirror that of BAFF, as APRIL has not 








IL-2 100, 500, 1000 U/ml 30, 32 N/A IL-2R
IL-6 10, 50, 100 ng/ml 31, 32 N/A IL-6R
IL-15 10, 50, 100 ng/ml 32, 38, 39 N/A IL-15R
IL-21 10, 50, 100 ng/ml 28, 31 10, 50, 100 ng/ml IL-21R
BAFF 10, 50, 100 ng/ml 27, 38 N/A BAFF-R, BCMA, TACI
APRIL 10, 50, 100 ng/ml 32 N/A TACI, BCMA
CpG ODN2006 0.5, 2.5, 10 μg/ml 12, 28, 34, 40 0, 0.25, 1 (µg/ml TLR9
PWM 5, 50, 100 ng/ml 28, 34, 41 N/A TLR2 or indirectly via T cells
R848 0.5, 1, 5 μg/ml 30, 42 0, 0.25, 0.5 (µg/ml TLR7/TLR8
HV13280 cells Utilised at a ratio of 1:4 
with memory B cells
1:5, 1:2, 1:1 CD40
Page 4 of 25
Wellcome Open Research 2018, 2:97 Last updated: 08 MAR 2018
Cell culture and stimulation conditions
RPMI-1640 media (Sigma Aldrich) supplemented with L-glutamine, 
Penicillin/Streptomycin and 10% fetal bovine serum (FBS) 
(Sigma Aldrich) was used throughout the study. Isolated memory 
B cells were set at different cell densities in 96-well U-bottom 
plates (2×103 cells/well in 250 μl) or in 24-well flat bottom 
plates (1×106 cells/well in 1 ml). Small-scale expansions were 
used for sequencing and Ig quantification, large-scale expansions 
were used for phenotyping of expanding cells by flow cytometry. 
Before adding memory B cells, each well was seeded with irra-
diated (2,000 cGray) HV13280 feeder cells (CD154+ HEK-293T 
cells, kindly provided by L. Liao’s lab, Duke University, Durham, 
NC, USA) at ratios varying from 1:1 to 1:50 (HV13280:memory 
B cell). After the addition of memory B cells, cultures were 
stimulated with iterative combinations of the following stimuli: 
recombinant human interleukin (IL)-2 (100–1000 U/ml), IL-6 
(10–100 ng/ml), IL-15 (10–100 ng/ml), IL-21 (10–100 ng/ml), 
APRIL (10–100 ng/ml), BAFF (10–100 ng/ml), CpG ODN2006 
(0.25–10 μg/ml) (HyCult Biotech, Uden, Netherlands); R848 
(0.25–5 μg/ml; Invivogen, Toulouse, France); PWM (5–100 ng/ml; 
Sigma Aldrich). Cells were then cultured for 5 or 10 days at 37°C 
5% CO2. All recombinant proteins were ordered from Peprotech 
(London, UK) unless otherwise stated.
ELISA
Total IgG, IgA and IgM in culture supernatants were measured 
by ELISA. Nunc MaxiSorp 96 well plates were coated overnight 
at 4°C with 100 μl goat anti-human kappa/lambda (Southern 
Biotech, Cambridge, UK; product number: 2060-01/2070-01) 
diluted 1:500 in PBS. Plates were washed with PBS/0.05% Tween-
20 and blocked with 200 μl PBS/0.05% Tween-20/1% bovine 
serum albumin (BSA) (Sigma Aldrich) for 1 hour at 37°C. Plates 
were then washed and 50 μl of culture supernatant diluted in 
blocking buffer added to each well and incubated for 1 hour at 
37°C. Following incubation and washing, 100 μl of detection 
antibody diluted in blocking buffer was added: goat anti-human 
peroxidase IgG (1:20,000), IgA (1:10,000), and IgM (1:1,000) 
(Sigma Aldrich; product numbers: A0170, A0295, and A6907, 
respectively). Plates were washed and developed using TMB 
(KPL, Middlesex, UK), stopped using 1% HCl stopping solution 
(KPL) and read using the VersaMax microplate reader (Molecular 
Devices, Berkshire, UK).
Flow cytometry and cell sorting
Memory B cells were stained with 5 μM Cell Trace Violet 
(ThermoFisher Scientific, Paisley, UK) as directed in the datash-
eet, and incubated overnight at 37°C 5% CO2. The cells were 
then washed and cultured using the optimal DoE conditions. For 
flow cytometry experiments cells were then stained with Aqua 
Live/Dead cell viability dye (BD Biosciences, Oxford, UK) as per 
manufacturer’s instruction. Cells were then stained with the phe-
notyping panel shown in Table 2. The cells were analysed using 
an LSR Fortessa II cytometer (BD Biosciences) at baseline, day 
5 and day 10 of culture. The gating strategy used can be seen in 
Supplementary Figure 1. Purity of CD27+ memory B cells follow-
ing isolation by magnetic selection was also determined using this 
panel. For FACS, memory B cells were sorted based upon IgD and 
IgM expression into 4 sub-populations (IgD+ IgM-, IgD+ IgM+, IgD- 
IgM+, IgD- IgM-) as shown in Supplementary Figure 1. Cell sorting 
was carried out using a BD FACSAria III.
Library preparation for next generation sequencing
Following cell sorting, the four memory B cell subsets were 
cultured using the optimal DoE expansion conditions with cells 
removed and IgH sequencing carried out at baseline, day 5 and 
10 of culture. RNA extraction was performed using RNeasy 
Micro Kit (Qiagen, Manchester, UK) according to manufac-
turer’s protocol. Reverse transcription (RT) was run as a 20 μl 
reaction with SuperScript® III (Thermo Fisher, Loughborough, 
UK). cDNA was cleaned-up with Agencourt AMPure XP beads 
(Beckman Coulter, Buckinghamshire, UK). Reagents for each 
RT step were divided in two mixes: Mix1 (RNA template, bar-
coded multiplex Constant region primer set [10 μM each primer], 
nuclease-free water) was incubated for 1 min at 70°C and then 
immediately transferred on ice for 1 min; Mix2 (4 μl 5x FS 
buffer, 1 μl DTT [0.1 M], 1 μl dNTP [10mM], 1 μl SuperscriptIII) 
Table 2. B cell phenotyping flow cytometry panel. Volumes shown represent the staining volumes used, 
topped up to 100 μl with FACS buffer (1×PBS, 25mM Hepes [Sigma Aldrich], 1mM EDTA [Sigma Aldrich], 
2.5% FBS), per 1×106 cells. Volumes used were titrated in-house.
Marker Fluorophore Channel Supplier Clone Isotype Volume
CD3 V500 405-525/50 BD: 561416 UCHT1 Mouse IgG1 κ 1.25μl
CD4 V500 405-525/50 BD: 560768 RPA-T4 Mouse IgG1 κ 1.25μl
CD14 V500 405-525/50 BD: 561391 M5E2 Mouse IgG2a κ 2.5μl
CD19 BV605 405-605/12 Biolegend (London, UK): 
363024
SJ25C1 Mouse IgG1 κ 1.25μl
CD27 PE Cy7 561-780/60 Biolegend: 356412 M-T271 Mouse IgG1 κ 2.5μl
CD38 APC 640-670/14 Biolegend: 356606 HB-7 Mouse IgG1 0.6μl
CXCR4 PE 561-582/15 Biolegend: 306506 12G5 Mouse IgG2a κ 0.6μl
IgM FITC 488-530/30 Biolegend: 314506 MHM-88 Mouse IgG1 κ 1.25μl
IgD PE-CF594 561-610/20 BD: 562540 IA6-2 Mouse IgG2a κ 1.25μl
IgG APC-H7 640-780/60 BD: 561297 G18-145 Mouse IgG1 κ 1.25μl
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was added and incubated at 50°C for 60 min followed by inacti-
vation at 70°C for 15 min. Cleaned cDNA was amplified with 
V-gene multiplex primer mix (10 μM each forward primer) and 
3’ universal reverse primer (10 μM) using KAPA Real-Time 
Library Amplification Kit (KAPA Biosystems, Wilmington, MA, 
USA) under the following thermal cycling conditions: 1 step 
(95°C - 5 min); 5 cycles (98°C - 5 sec; 72°C - 2 min); 5 cycles 
(65°C - 10 sec, 72°C - 2 min); 25 cycles (98°C - 20sec, 60°C - 
1 min, 72°C - 2 min); 1 step (72°C - 10 min). Nucleotide sequences 
for primers can be seen in Table 3.
Next generation sequencing and barcode filtering
MiSeq libraries were prepared using Illumina protocols 
and sequenced using 300bp paired-ended MiSeq (Illumina, 
Cambridge, UK). Raw MiSeq reads were filtered for base quality 
(median Phred score >34) using the QUASR program version 6.08 
(http://sourceforge.net/projects/quasr/43) MiSeq forward and 
reverse reads were merged together if they contained identical 
overlapping region of >50bp, or otherwise discarded. Universal 
barcoded regions were identified in reads and orientated to read 
from V-primer → constant region primer. The barcoded region 
within each primer was identified and checked for conserved 
bases (i.e. the T’s in NNNNTNNNNTNNNNT). The reads were 
checked for homology to the first 50bp of the reference constant 
region genes from the IMGT database (http://www.imgt.org/ 
vquest/refseqh.html)44 by k-mer matching (where k=10bp). 
The closest matching constant region allele was identified, and 
information retained throughout the analysis. Primers and 
constant regions were trimmed from each sequence, and sequences 
were retained only if there was >80% sequence certainty 
between all sequences obtained with the same barcode, otherwise 
discarded. Sequences without complete reading frames and non- 
immunoglobulin sequences were removed and only reads with 
significant similarity to reference IgHV and J genes from the 
IMGT database were retained using BLAST45.
Analysis of VH SHM, CDRH3 length and isotype-
distribution of BCR repertoires
Isotype information was derived from constant region 
assignment of each BCR read according to IMGT. Isotype struc-
ture of each sorted B cell population across the three time points 
(baseline, day 5 and day 10) was calculated as percentage of 
reads from a given sample, assigned to each isotype. SHM levels 
and CDRH3 length was determined using IMGT-HighV-Quest 
(version 1.5.0) (https://www.imgt.org/HighV-QUEST/).
Design of experiments approach
For the DoE approach, we utilised a full factorial design 
where each of the four chosen stimuli (IL-21, HV13280 cells, 
CpG ODN2006 and R848) would be tested for their effect on 
Ig secretion as measured by ELISA, at three different chosen 
concentrations, generating a total of 34 = 81 different possible 
conditions. The first order and second order sensitivity indices 
reflecting the effect of each stimuli on Ig secretion and the 
p-values (shown to 4 decimal places) were then determined 
using a custom MATLAB script based on the use of an N-way 
ANOVA (see Data availability).
Statistics
Statistical tests were performed in MATLAB (Version 2014; 
MathWorks, Natick, MA, USA) or in Prism (Version 7; Graph-
Pad, San Diego, CA, USA). For the final comparison set, two-way 
analysis of variance (ANOVA) with Tukey’s post-hoc test was 
used for statistical analysis.
Results
Memory B cells isolated from PBMC are efficiently 
differentiated into high Ig secretory ASC by culture with 
optimal levels of IL-21, TLR and CD40 co-stimulation
In order to identify the conditions best suited for inducing 






IGHA TGTCCAGCACGCTTCAGGCTNNNNTNNNNTNNNNGAYGACCACGTTCCCATCT C region
IGHM TGTCCAGCACGCTTCAGGCTNNNNTNNNNTNNNNTCGTATCCGACGGGGAATTC C region
IGHD TGTCCAGCACGCTTCAGGCTNNNNTNNNNTNNNNGGGCTGTTATCCTTTGGGTG C region
IGHE TGTCCAGCACGCTTCAGGCTNNNNTNNNNTNNNNAGAGTCACGGAGGTGGCATT C region
IGHG TGTCCAGCACGCTTCAGGCTNNNNTNNNNTNNNNAGTAGTCCTTGACCAGGCAG C region
VH1-FR1 GGCCTCAGTGAAGGTCTCCTGCAAG V region
VH2-FR1 GTCTGGTCCTACGCTGGTGAAACCC V region
VH3-FR1 CTGGGGGGTCCCTGAGACTCTCCTG V region
VH4-FR1 CTTCGGAGACCCTGTCCCTCACCTG V region
VH5-FR1 CGGGGAGTCTCTGAACATCTCCTGT V region
VH6-FR1 TCGCAGACCCTCTCACTCACCTGTG V region
3’universal TGUCCAGCACGCTUCAGGC n/a
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literature review of suggested culture conditions was carried out 
(Table 1). Following identification of a wide range of conditions 
used for the induction of memory B cell differentiation, a check-
erboard approach combining any two suggested factors with mem-
ory B cells and HV13280 cells (CD154+ feeder cell line) was set 
up. Each two-way crossover was carried out with factors at one 
of three chosen concentrations, these concentrations were chosen 
to be reflective of the publications that they were obtained from. 
All possible crossovers of the listed factors were carried out 
except for conditions combining two pattern recognition recep-
tor (PRR) agonists, such as R848 and Pokeweed mitogen 
(PWM). CD40 stimulations were used for all checkerboard 
expansions as they were the one constant used throughout the 
published differentiation conditions and thus seen to be essential.
After 5 days of culture, total Ig (IgG + IgA) in the culture 
supernatants was measured by ELISA. Ig in the supernatant 
acts as a readout for memory B cell differentiation as the 
memory B cells differentiate from being surface Ig-expressing 
cells to Ig-secreting cells. The results suggested that a combina-
tion of either IL-21 and CpG or IL-21 and R848 induced the 
highest levels of Ig secretion (Figure 1A, Supplementary 
Figure 2). These results matched a previously published trend28.
In an attempt to drive further differentiation and expansion, com-
binations of the CD40 stimulation, IL-21, R848 and CpG were 
assessed (Figures 1B–D), with memory B cells cultured for 5 
(Figure 1B) or 10 days (Figure 1C). For these expansions the 
R848 concentrations were lowered in an attempt to prevent 
over-stimulation when combining TLR agonists. This final screen 
identified that a 10-day culture period induced higher levels 
of memory B cell differentiation and that there was a trend for 
higher Ig secretion with lower levels of CpG ODN2006 and R848 
combined.
A full factorial DoE approach identified significant individual 
effects of IL-21, R848 and CD154 on Ig secretion from 
memory B cells
Following the identification of CD40 stimulation, IL-21, 
R848 and CpG as having the greatest capacity for inducing mem-
ory B cell expansion/differentiation over a 10-day culture period, 
these expansion stimuli were combined in a targeted approach that 
would allow their individual effects on memory B cell differentia-
tion to be titrated. We utilised a full factorial DoE approach with 
four expansion stimuli at three set levels (low/intermediate/ 
high) (Table 1), generating 81 possible combinations (34). The 
concentrations chosen for this approach were based on the trends 
observed in data presented in Figure 1. 2×103 memory B cells 
from three individual donors were cultured in triplicate with 
each possible combination over a 10-day culture period and 
total Ig (IgG, IgM & IgA) levels in the supernatant measured.
A DoE full factorial approach allows for the impact on Ig output 
to be determined for each stimulant, at each set concentration 
(Figures 2A–E, Supplementary Figure 3). Through the use of a 
MATLAB script the mean Ig detected in the supernatant whilst 
“variable x” remains constant and all other variables altered 
can be calculated, ultimately allowing the impact of subsequently 
changing the concentration of “variable x” on Ig secretion to be 
measured. Subsequently 2nd order interactions and their sig-
nificance can also be assessed, as there are 9 combinations per 
donor where two stimulants will remain at the same 
concentration whilst all other stimulants are being altered.
We determined that a combination of high IL-21 (Figure 2A), 
high R848 (Figure 2B) and high CD40 stimulation (Figure 2D) 
induced the highest levels of Ig secretion, whilst all hav-
ing a significant first order impact on Ig secretion (Figure 2E). 
Importantly, no stimulant appeared to bias the induction of secre-
tion of one isotype over another. As well as having significant first 
order effects, the combination of IL-21 and CD40 stimulation had 
a significant second order impact on IgG, IgM & IgA secretion 
(Figures 3C–F), whilst R848 in combination with IL-21 and 
CpG in combination with CD40 stimulation had significant 
effects on IgM secretion (Figures 3A and B). All other sec-
ond order interactions were not significant (Supplementary 
Figure 4). Of note was the determination that CpG did not 
impact Ig secretion (Figure 2C), with total Ig in culture 
supernatant remaining the same when CpG was at 0, 0.25 
or 1 μg/ml. Therefore, we defined the optimal expansion 
conditions as 1:1 MBC:HV13280 ratio, 100 ng/ml IL-21, and 
0.5 μg/ml R848.
We subsequently compared total Ig (IgG, IgM & IgA) secre-
tion induced by the DoE conditions to a literature comparator 
(IL-2 plus R848)30 and IL-21 plus CpG (optimal condition in 
the original 2 parameter screen). Memory B cells were stimu-
lated with a number of the top DoE conditions, IL-2 and R848 
used at concentrations selected to reflect those detailed in the 
literature or IL-21 and CpG at concentrations to mirror those 
in the original screen (Supplementary Figure 5B). HV13280 
cell:memory B cell ratios of 1:1 identified by the DoE process as 
optimal were used throughout for IL-2 plus R848 and IL-21 plus 
CpG.
The results showed that the identified DoE conditions signifi-
cantly induced (p=0.0003) higher Ig secretion levels than IL-2 and 
R848 (Supplementary Figures 5A and C). The optimal 
condition also induced significantly higher levels of Ig secre-
tion than the majority of IL-21 and CpG combinations. However, 
although the top DoE condition induced higher levels of 
Ig secretion than IL-21 and CpG combination 6, the difference 
was not significant.
Memory B cells differentiate into plasmablast-like cells 
upon stimulation with optimal DoE conditions
Upon identification of the optimal memory B cell differentiation 
conditions through the use of a full factorial DoE approach, 
the differentiation of memory B cells over a 10-day culture 
period was tracked by flow cytometry. Freshly isolated CD27+ 
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Figure 1. CD40 stimulation  in combination with  IL-21 & TLR stimulation of memory B cells over a 10 day culture period  induces 
high levels of Ig secretion. (A) 2×103 memory B cells were cultured for 5 days with HV13280 cells at a ratio of 4:1 with the addition of a 
checkerboard of different stimulants suggested to play a role in memory B cell expansion/differentiation (see Table 1). Total Ig (IgG + IgA) 
was measured in the culture supernatant by ELISA and the top readout for each crossover is shown. The full checkerboard screen can be 
seen in Supplementary Figure 2. (B and C) Total Ig (IgG + IgA) measured by ELISA in culture supernatant of memory B cells stimulated with 
HV13280 cells, IL-21, R848 and CpG at (B) day 5 and (C) day 10 of culture. (D) Composition of the stimulation mixtures used in B & C. Data 
is representative of one donor.
memory B cells were labelled with the cell tracking dye 
CellTrace™ violet, and put into culture with the optimal DoE 
expansion/differentiation conditions. Cells were phenotyped 
at baseline, day 5 and day 10 of culture. CellTrace™ violet 
identified multiple rounds of cell division by the end of day 10 
(Figures 4A–C). Additionally, cells progressively lost expres-
sion of surface Ig, as demonstrated by a loss in IgD and IgM 
staining (Figures 4D–F). The loss of surface Ig was further con-
firmed by a coincident loss in IgG staining (Figures 4G–I). 
This result confirmed that the culture conditions were not 
inducing class switching of previously IgD and/or IgM positive 
cells to double negatives, but were rather causing the loss of 
surface Ig expression. Finally an increase in CD38 expression 
was also detected (Figures 4J–L). Increased CD38 expression was 
particularly telling as it is a B cell marker routinely used for the 
identification of ASCs, such as plasmablasts and plasma cells46,47. 
Interestingly although the surface Ig expression was rapidly 
decreased, CD38 expression levels changed relative to the 
number of divisions that had taken place (Figures 4M and N). 
This suggests that as the cells proliferate they progressively 
differentiate towards ASCs.
Ultimately, by the end of the 10-day culture period, CD27+ 
memory B cells had undergone multiple rounds of cell 
division, differentiating from CD38-, surface Ig expressing cells, 
to CD38+ plasmablast-like cells that had lost the majority of 
their surface Ig expression. These phenotypical changes 
coincide with the ability of the cells to secrete Ig, as was detected 
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Figure 2. A Design of Experiments approach identifies IL-21, CpG and CD40 stimulation as having significant first order effects on 
IgG, IgM & IgA secretion by differentiated memory B cells. 2x103 memory B cells were cultured with all possible combinations of HV13280 
cells, IL-21, R848 and CpG at three set concentrations for 10 days, after which total Ig (IgG, IgA & IgM) was measured in culture supernatant 
by ELISA. (A–D) Using a Matlab script, the effect of (A) IL-21, (B) R848, (C) CpG and (D) CD40 stimulation at the chosen concentrations on 
IgG, IgM and IgA secretion could be determined. (E) P-values showing the effects of each expansion stimulus on IgG, IgM and IgA secretion 
into culture supernatant over the 10 day culture. Data shows a summary of three independent donors.
in culture supernatant by ELISA. Therefore, the optimised 
DoE expansion conditions promote the phenotypic and 
functional differentiation of memory B cells into ASCs.
The DoE optimised memory B cell expansion/differentiation 
conditions do not induce Ig locus genotypic changes
One of the key issues with ex vivo proliferation and 
differentiation of memory B cells is ensuring that undesirable 
Ig locus changes that could alter the reactivity of the secreted 
immunoglobulin are not induced. To detect such changes, we 
employed a sequencing approach where we first sorted each 
memory B cell subset (IgM+IgD+, IgM+IgD- and IgM-IgD-) having 
retained a sample for baseline reads and then cultured for 5 and 
10 days before next generation sequencing of the total population 
Ig transcripts. We first looked at CSR events, and the data show 
that the IgM+IgD+ and IgM+IgD- subsets remain largely IgM+ 
throughout the culture period (Figures 5A, B and I, 
Supplementary Figures 6A and B). Whilst the IgM- IgD- popu-
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Figure 3. A Design of Experiments approach identifies IL-21 & CD40 stimulation as having the greatest second order  interaction 
effect on  IgM,  IgG &  IgA secretion by differentiated memory B cells.  (A–E) Colour plots of the significant second order interactions 
showing their effect on IgM, IgG and IgA secretion. The non-significant second order interaction colour plots can be seen in Supplementary 
Figure 5. (F) P values of the second order interactions on IgG, IgM and IgA secretion into culture supernatant over the 10 day culture. Data 
shows a summary of three independent donors.
Page 10 of 25
Wellcome Open Research 2018, 2:97 Last updated: 08 MAR 2018
Figure  4.  Upon  stimulation with  the  optimal  Design  of  Experiments  (DoE)  expansion  conditions, memory B  cells  progressively 
differentiate into antibody secreting cells. Cells were stained with cell trace violet and cultured with the optimised DoE conditions over 10 
days, CD19+ CD27+ lymphocytes were phenotyped at baseline, day 5 and day 10. Baseline, day 5 and day 10 (A–C) cell trace violet levels, 
(D–F) surface IgD and IgM expression, (G–I) surface IgG expression and (J–L) CD38 expression. (M and N) Mean fluorescence intensity 
(MFI) values for each fluorophore relative to the cell trace violet (CTV) peak. A minimum of 5,000 cell trace violet positive events were acquired 
for each time-point. Data is representative of two independent donors.
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Figure 5. Design of Experiments expansion/differentiation conditions do not induce undesirable Ig genotypic changes.  IgM+ IgD+, 
IgM+ IgD-, IgM- IgD- memory B cells were isolated by cell sorting and cultured using the optimised conditions. Samples were taken at 
baseline, day 5 and day 10 where Ig transcripts were analysed. (A–C) Ig constant region transcripts measured from each subset at baseline, 
day 5 and day 10 of culture expressed as a percentage of isotype-specific Ig reads from the total Ig repertoire. (D) VH SHM of each memory 
B cell subset across the three timepoints as a percentage of the total VH segment length at nucleotide level. (H) Average CDRH3 length 
in nucleotides of Ig transcripts measured for each population across the different time points. (F–H) Density plots of CDRH3 length for the 
individual subsets across the three time points. CDRH3 length is shown as nucleotides on the x axis. (I) IgG, IgA and IgM levels in culture 
supernatant when memory B cell subsets are cultured separately. Data is representative of two independent donors.
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lation showed a distribution of different IgG and IgA isotypes, 
which largely remained within their relative proportions 
over the 10-day culture period (Figures 5C and I, Supplementary 
Figure 6C). Overall these data suggest that the culture conditions 
do not induce CSR events both at the RNA and protein level.
To assess levels of SHM, we first looked at how the level of VH 
SHM changed across the 10 day culture period for each subset 
(Figure 5D). This data showed that the level of SHM did not 
increase across the 10 day culture period. Subsequently, we 
investigated how CDRH3 length changed across the 10 day 
culture period. The results show that within each subset the 
average CDRH3 length remains almost constant in terms of 
nucleotide length (Figure 5E) across the 10-day culture period, 
with a more detailed analysis showing that for each subset the 
densities of the different CDRH3 lengths present in the popu-
lation appear to remain constant across the different time points 
(Figures 5F–H, Supplementary Figures 6E–G). Overall this 
data suggests that although the culture conditions were inducing 
proliferation and differentiation of memory B cells they were not 
inducing SHM events.
Discussion
The role of memory B cell subsets in response to vaccination and/
or infection is only just starting to become clear. Differences in 
location, kinetic time point and type of vaccination or 
infection all influence the development of different memory B 
cell subsets. Importantly it is not just phenotype that distinguishes 
these cells from one another, they may each have differences 
in functionality11, switch capacity48 and overall numbers in 
responses to different types of challenge.
To effectively study memory B cell subsets, we carried out a wide 
screen of memory B cell expansion and differentiation condi-
tions and utilised a novel DoE process to optimise conditions that 
would lead to the highest levels of proliferation and Ig secretion. 
Subsequently the optimal conditions were characterised to 
ensure that they did not induce any undesirable changes.
Our original wide screening process encapsulated over 200 differ-
ent culture conditions taken from the literature. The results from 
this section clearly demonstrated a trend towards higher Ig secre-
tion in those wells where CD40 stimulation was combined with 
IL-21 and some form of PRR agonist. The use of IL-21 for 
ex vivo memory B cell proliferation and differentiation 
stems from its essential role in the germinal center49 where it 
acts directly on B cells. Therefore, IL-21 serves an essential 
role in several different published protocols for both human and 
murine memory B cell culture26,29,50. The combination of CD40 
stimulation, IL-21 and CpG for memory B cell culture has been 
previously published28. However, what had not been attempted 
was the combination of CD40 stimulation, IL-21, CpG and R848, 
which formed the basis of the top two conditions identified from 
our primary screen.
To try and induce maximal memory B cell proliferation and 
differentiation, we combined the top two conditions from 
our original screen using a structured DoE full factorial design. 
The DoE full factorial design approach offers a powerful 
statistical tool to answering biological questions and can ultimately 
save time and costs, and streamline the addressing of research 
questions from in vitro work through to in vivo, as reviewed by 
Shaw et al.51. This approach suited our needs, as it allowed 
us to determine the impact of each stimulant on Ig secretion. 
A total of 81 possible combinations (3 concentrations of 
4 different stimulants) were assessed. The data showed 
that a combination of 100 ng/ml IL-21, 0.5 μg/ml R848 and high 
levels of CD40 stimulation all significantly enhanced Ig secre-
tion. The fact that CpG did not significantly enhance Ig secre-
tion was surprising, particularly as the CD154, IL-21, CpG 
condition induced higher levels of Ig than CD154, IL-21 and 
R848 in the original screen. The explanation for this likely lies 
in the fact that the concentrations used in the DoE approach were 
chosen based on trends seen in the original screen. The lack of 
an effect then witnessed by CpG was possibly due to a redun-
dancy mechanism, whereby the R848 signal that was now 
at a more optimal concentration than in the original screen 
outcompeted the CpG, as both R848 and CpG use TLRs which 
signal through the MyD88 adaptor protein52. Also of note from 
the DoE data is that although we observed a potential pla-
teau in Ig secretion with increasing concentrations of CD40 
stimulation, IL-21 and R848 responses were still trending 
upwards. Therefore, it is possible that higher concentrations of 
each of these stimulants could further enhance expansion and 
Ig secretion. Finally, and perhaps most importantly, the DoE 
approach was capable of showing that neither IL-21, R848 nor 
CD40 stimulation at any concentration appeared to bias Ig secre-
tion towards either IgG, IgA or IgM. This suggested that the 
optimal conditions were not biased towards inducing prolifera-
tion and or differentiation of either IgM+ IgD+, IgM+ IgD-, IgM- 
IgD- memory B cell subsets.
To confirm if the DoE process was beneficial, we went on to 
compare the Ig secretion induced by IL-2 & R848, IL-21 & 
CpG from our original screen, and the DoE optimised conditions. 
Overall the results justified the DoE optimisation approach. How-
ever, the results did show that although inducing significantly 
higher levels of Ig secretion than IL-2 and R848, the difference 
between the DoE conditions and the IL-21 & CpG conditions 
was not always significant, despite a trend towards higher Ig 
secretion with the DoE conditions. The lack of an effect seen 
with the IL-2 and R848 was rather surprising. The original pub-
lication on the optimisation of the IL-2 and R848 conditions by 
Pinna et al.30 was for memory B cells within a PBMC scaf-
fold, and the authors also showed that increased levels of CD40 
stimulation inhibit memory B cell proliferation. Therefore, 
it is possible that our CD154 levels that were optimised for 
the IL-21 conditions could have been inhibitory in the IL-2 
and R848 cultures. 
To characterise how the memory B cell culture conditions 
impacted the Ig locus, we employed an IgH deep sequencing plat-
form. One issue we faced in our sequencing work was the pres-
ence of IgG1 and IgA1 transcripts detected at baseline in the IgM+ 
subsets. This result was likely caused by plasmablast contamina-
tion during the sorting process, as these transcripts were clonal 
in nature and were rapidly lost during the culture process. 
Interestingly despite inducing B cell activation and differen-
tiation, the culture conditions did not induce CSR at either the 
genomic or protein level. Although a possibly unexpected result, 
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since CD40 engagement53 and IL-21 induce activation induced 
cytidine deaminase (AID) expression29, which plays a key role 
in both the CSR and SHM pathways54, this result does mirror a 
previously published result, which showed that IL-21 induced 
AID expression but no detectable SHM events29. One possible 
explanation of our results comes from a recent publication that 
showed that CSR takes place much more readily in a hypoxic 
environment, likely recapitulating the environment in the germinal 
centre55. Although this work was carried out using a murine model, 
it is possible that the same “checkpoint” exists in humans and 
provides a probable explanation for why we do not see CSR in 
our cultures. It would therefore be interesting to set up memory 
B cell cultures in such a hypoxic environment and test if we 
see CSR events and SHM taking place more readily than in our 
normoxic culture conditions. Importantly analysis of the Ig VH 
region highlighted that the culture conditions did not appear 
to induce SHM with levels of VH SHM staying relatively 
constant for each subset across the 10-day culture period. 
However, to fully confirm if the culture conditions impact 
the Ig locus monoclonal cell lines would need be cultured and 
then IgH sequencing carried out as was done by Kwakkenbos 
et al.24.
Recently, the importance of IgM+ memory B cells in mediating 
long term immunity in murine models has started to become 
apparent16,17,56 and this work is now starting to be translated into 
humans. For example, recent work has shown that in humans the 
majority of circulating long lived tetanus toxoid specific mem-
ory B cells are IgM+57. However, these cells are extremely rare 
and the authors did not delineate whether these cells were IgM+ 
IgD+ and/or IgM+ IgD-. By inducing robust expansion and dif-
ferentiation of IgG+, IgA+, IgM+ IgD+ and IgM+ IgD- cells, 
whilst not inducing CSR, the methods described in this manu-
script will allow the responsiveness of rare memory B cells to be 
assessed irrespective of isotype. This could prove vitally important 
for the study of rare subsets including IgM expressing subsets 
such as B-1 cells.
In conclusion, our data show that a combination of IL-21, R848 and 
CD40 stimulation is optimal for the induction of purified memory 
B cell proliferation and differentiation into ASCs from a 
number of different memory B cell subsets. Importantly, 
characterisation of these culture conditions shows that they 
do not induce any undesired genotypic changes and are not 
biased towards any one memory B cell subset studied. There-
fore, these conditions provide a valuable starting point for the 
investigation of memory B cell subset responses where prolifera-
tion is required to increase rare cell number, and differentiation is 
required to allow for functionality assessments.
Data availability
All raw ELISA and FACS data, and the custom MATLAB 
script for DoE are available on OSF: http://doi.org/10.17605/OSF.
IO/W96YG58.
For sequencing data, accession numbers can be found in Table 4. 
It should be noted that access to samples must be requested 
from the Data Access Committee (DAC), whose contact details 
can be found on the EGA study page, accessible through the 
study accession number (EGAS00001002633) or by emailing 
Table 4. B cell sequencing accession numbers. EGA 
accession numbers and sample identifiers. EGA study accession 





1 IgM+ IgD+ 0 EGAN00001588556
1 IgM+ IgD- 0 EGAN00001588558
1 IgM- IgD- 0 EGAN00001588559
1 IgM+ IgD+ 5 EGAN00001588560
1 IgM+ IgD- 5 EGAN00001588561
1 IgM- IgD- 5 EGAN00001588562
1 IgM+ IgD+ 10 EGAN00001588563
1 IgM+ IgD- 10 EGAN00001588564
1 IgM- IgD- 10 EGAN00001588565
2 IgM+ IgD+ 0 EGAN00001588549
2 IgM+ IgD- 0 EGAN00001588541
2 IgM- IgD- 0 EGAN00001588542; 
EGAN00001588543
2 IgM+ IgD+ 5 EGAN00001588575
2 IgM+ IgD- 5 EGAN00001588550
2 IgM- IgD- 5 EGAN00001588551
2 IgM+ IgD+ 10 EGAN00001588552
2 IgM+ IgD- 10 EGAN00001588554
2 IgM- IgD- 10 EGAN00001588555
datasharing@sanger.ac.uk. The requester will be required to 
sign a data access agreement, which is in place to protect the 
identity of the sample donor via a managed access system.
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Supplementary material
Supplementary Figure 1: Gating strategy used for flow cytometry experiments including cell sorting, expansion phenotyping and 
MACS CD27+ selection purity analysis. (A) A time gate was used to make sure the sample was acquired without issue, (B) lymphocytes 
were then gated on using a FSC-A vs SSC-A gate and (C) single cells by setting FSC-H vs FSC-A gate. Memory B cells were then identified 
by gating on (D) CD19+ live cells, which were negative for CD3, CD4 & CD14, followed by selection of (E) CD27+ cells. Memory B cells 
and antibody secreting cells could then be phenotyped by looking at (F) cell trace violet levels, (G) IgD/IgM subsets, (H) IgG expression 
and (I) CD38 expression. (F) Cell trace violet peaks were identified using the proliferation tool in Flow Jo version 9.
Click here to access the data.
Supplementary Figure 2: A wide screen of memory B cell differentiation stimuli identifies CD40 stimulation in combination with 
either IL-21 & CpG or IL-21 & R848 as the optimal stimulants. 2×103 memory B cells were cultured at a ratio of 4:1 with HV13280 
cells and a checkerboard of cytokines and TLR agonists suggested to play a role in memory B cell expansion/differentiation at different 
concentrations. Heat map showing total Ig (IgG + IgA) secreted in culture supernatant as determined by ELISA after 5 days of culture. Data 
is representative of one donor.
Click here to access the data.
Supplementary Figure 3: A Design of Experiments approach identifies the effects of IL-21, R848, CpG ODN2006 & CD40 stimulation 
on IgG, IgM and IgA secretion by differentiating memory B cells. 2×103 memory B cells were cultured with all possible combinations 
of HV13280 cells, IL-21, R848 and CpG at three set concentrations for 10 days, after which total Ig (IgG, IgA & IgM) was measured in 
culture supernatant by ELISA. Each data point shows the average Ig output measured from 81 data points where the stimulant of interest 
was at a set concentration, but all other stimulants were being utilised in every possible combination (33 for 3 donors = 81). “Errors bars” 
show the variation of Ig output measured across the 81 data points including the statistical error and, more importantly, the true effects of 
varying all other stimulant concentrations within their ranges. Thus these bars show how much the Ig output changes in response to three of 
the stimulants when the fourth one is fixed. Data shows a summary of three independent donors.
Click here to access the data.
Supplementary Figure 4: A Design of Experiments approach identifies a number of non-significant second order interaction effects 
on IgM, IgG and IgA secretion by differentiated memory B cells. Following stimulation of 2×103 memory B cells with iterative combi-
nations of HV13280 cells, IL-21, CpG ODN2006 and R848 at three set concentrations over a 10-day culture period, IgG, IgM & IgA (ng/ml) 
secreted into the culture supernatant was measured by ELISA. (A–M) A Matlab script was then used to determine the second order interac-
tion effects of the chosen stimulants at each level on IgM, IgG & IgA secretion, these colour plots show the non-significant second order 
interactions. Data shows a summary of three independent donors.
Click here to access the data.
Supplementary Figure 5: The optimal Design of Experiments (DoE) expansion conditions induce high levels of Ig secretion. 2×103 
memory B cells were cultured with combinations of (B) HV13280 cells, IL-2 & R848, HV13280 cells, IL-21 & CpG as a comparator to 
the original screening results and the top DoE conditions identified, over 10 days. (A) Total Ig (IgG, IgM & IgA) in culture supernatant 
was then measured by ELISA, errors bars show standard deviation. (C) Statistical analysis of ELISA results (total Ig) as determined by 
two-way ANOVA with Tukey’s multiple comparison test. p>0.05 (green), p ≤ 0.05 (yellow), **p ≤ 0.01 (orange), ***p ≤ 0.001 (light red), 
and ****p ≤ 0.0001 (red). Data shows a summary of three independent donors.
Click here to access the data.
Supplementary Figure 6: Repeat Design of Experiments expansion/differentiation conditions do not induce undesirable Ig geno-
typic changes. IgM+ IgD+, IgM+ IgD-, IgM- IgD- memory B cells were isolated by cell sorting and cultured using the optimised conditions. 
Samples were taken at baseline, day 5 and day 10 where Ig transcripts were analysed. (A–C) Ig constant region transcripts measured from 
each subset at baseline, day 5 and day 10 of culture expressed as a percentage of isotype-specific Ig reads from the total Ig repertoire. 
(D) VH SHM of each memory B cell subset across the three timepoints as a percentage of the total VH segment length at nucleotide level. 
(E–G) Density plots of CDRH3 length for the individual subsets across the three time points, CDRH3 length is shown as nucleotides on 
the x axis.
Click here to access the data.
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